Antepartum and postpartum maternal plasma levels of E-selectin and VE-cadherin in preeclampsia, gestational proteinuria and gestational hypertension

References

• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–799.
   PubMed Web of Science ®Google Scholar
• Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002;287:3183–3186.
   PubMed Web of Science ®Google Scholar
• Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005;60:807–816.
   PubMed Web of Science ®Google Scholar
• Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002;9:147–160.
   PubMed Web of Science ®Google Scholar
• Vestweber D, Winderlich M, Cagna G, Nottebaum AF. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 2009;19:8–15.
   PubMed Web of Science ®Google Scholar
• Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001;14:44S–54S.
   PubMed Web of Science ®Google Scholar
• Aydin S, Benian A, Madazli R, Uludag S, Uzun H, Kaya S. Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004;113:21–25.
   PubMed Web of Science ®Google Scholar
• Kim SY, Ryu HM, Yang JH, Kim MY, Ahn HK, Lim HJ, Shin JS, Woo HJ, Park SY, Kim YM, et al. Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J Korean Med Sci 2004;19:688–692.
   PubMed Web of Science ®Google Scholar
• Nadar SK, Yemeni EA, Blann AD, Lip GYH. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. Thromb Res 2004;113:123–128.
   PubMed Web of Science ®Google Scholar
• Chavarría ME, Lara-González L, García-Paleta Y, Vital-Reyes VS, Reyes A. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol 2008;137:157–164.
   PubMed Web of Science ®Google Scholar
• Morikawa M, Yamada T, Minakami H. Outcome of pregnancy in patients with isolated proteinuria. Curr Opin Obstet Gynecol 2009;21:491–496.
   PubMed Web of Science ®Google Scholar
• Holston AM, Qian C, Yu KF, Epstein FH, Karumanchi SA, Levine RJ. Circulating angiogenic factors in gestational proteinuria without hypertension. Am J Obstet Gynecol 2009;200:392.e1–392.e10.
   PubMed Web of Science ®Google Scholar
• Blechschmidt K, Mylonas I, Mayr D, Schiessl B, Schulze S, Becker KF, Jeschke U. Expression of E-cadherin and its repressor snail in placental tissue of normal, preeclamptic and HELLP pregnancies. Virchows Arch 2007;450:195–202.
   PubMed Web of Science ®Google Scholar
• Al-Nasiry S, Vercruysse L, Hanssens M, Luyten C, Pijnenborg R. Interstitial trophoblastic cell fusion and E-cadherin immunostaining in the placental bed of normal and hypertensive pregnancies. Placenta 2009;30:719–725.
   PubMedGoogle Scholar
• Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892–898.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No 33. Obstet Gynecol 2002;99:159–167.
   PubMed Web of Science ®Google Scholar
• Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5–15.
   PubMedGoogle Scholar
• Chong AY, Blann AD, Lip GY. Assessment of endothelial damage and dysfunction: observations in relation to heart failure. Q J Med 2003;96:253–267.
   Google Scholar
• Chaiworapongsa T, Romero R, Yoshimatsu J, Espinoza J, Kim Ym, Park K, Kalache K, Edwin S, Bujold E, Gomez R. Soluble adhesion molecule profile in normal pregnancy and preeclampsia. J Matern Fetal Neonatal Med 2002;12:19–27.
   PubMedGoogle Scholar
• Coata G, Pennacchi L, Bini V, Liotta L, Di Renzo GC. Soluble adhesion molecules: marker of pre-eclampsia and intauterine growth restriction. J Matern Fetal Neonatal Med 2002;12:28–34.
   PubMedGoogle Scholar
• Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18 weeks gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000;182:321–325.
   PubMed Web of Science ®Google Scholar
• Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M. Serum sFlt1:PIGF ratio, PIGF, and soluble endoglin levels in gestational proteinuria. Hypertens Pregnancy 2009;28:95–108.
   PubMed Web of Science ®Google Scholar
• Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol 2006;194:551–556.
   PubMed Web of Science ®Google Scholar
• Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med J 2002;325:157–160.
   PubMed Web of Science ®Google Scholar
• Sattar N. Do pregnancy complications and CVD share common antecedents? Atherosclerosis Suppl 2004;5(2):3–7.
   PubMedGoogle Scholar
• Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191–203.
   PubMed Web of Science ®Google Scholar
• Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003;42:39–42.
   PubMed Web of Science ®Google Scholar
• Chambers JC, Fusi L, Malik IS, Haskard DO, DeSwiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001;2985:1607–1612.
   Google Scholar
• Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008;28:223–232.
   PubMed Web of Science ®Google Scholar
• Groten T, Kreienberg R, Fialka I, Huber L, Wedlich D. Altered subcellular distribution of cadherin-5 in endothelial cells caused by the serum of pre-eclamptic patients. Mol Hum Reprod 2000;6:1027–1032.
   PubMed Web of Science ®Google Scholar